Medindia

X

Raptor Pharmaceutical Corp. Announces Publication of Results from Phase 2a Trial of DR Cysteamine for Treatment of Cystinosis

Tuesday, January 12, 2010 General News J E 4
Advertisement
Potential to Improve Treatment with Less Frequent Administration and Better Tolerability

For more information, please contact:

Kim R. Tsuchimoto, CFO

(415) 382-1390

ktsuchimoto@raptorpharma.com

The Ruth Group

Sara Ephraim Pellegrino (investors)

(646) 536-7002

spellegrino@theruthgroup.com

Janine McCargo (media)

(646) 536-7033

jmccargo@theruthgroup.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Idenix Pharmaceuticals Highlights Progress in Thre...
S
REMS Assessment Webinar to Examine How to Measure ...